Literature DB >> 2145957

Effects of felodipine on atrial natriuretic peptide in hypertensive non-insulin dependent diabetes mellitus.

R F Jeffrey1, S Capewell, J Brown, A Collier, C Hajducka, M R Lee.   

Abstract

Eighteen patients with non-insulin dependent diabetes mellitus and hypertension were treated during two 4 week periods with the calcium antagonist felodipine or placebo in a double-blind, randomised, cross-over study. Mean systemic blood pressure was significantly lower on felodipine, without producing a deleterious effect on diabetic control. Felodipine was associated with an increment in plasma renin concentration but plasma aldosterone and the renal outputs of sodium and dopamine were similar on both treatments. Plasma atrial natriuretic peptide levels were significantly reduced following felodipine treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145957      PMCID: PMC1368153          DOI: 10.1111/j.1365-2125.1990.tb03801.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1964-09       Impact factor: 4.030

2.  Bay K 8644, a voltage-sensitive calcium channel agonist, facilitates secretion of atrial natriuretic polypeptide from isolated perfused rat hearts.

Authors:  Y Saito; K Nakao; N Morii; A Sugawara; S Shiono; T Yamada; H Itoh; M Sakamoto; K Kurahashi; M Fujiwara
Journal:  Biochem Biophys Res Commun       Date:  1986-08-14       Impact factor: 3.575

3.  The effect of intravenous frusemide on urine dopamine in normal volunteers: studies with indomethacin and carbidopa.

Authors:  R F Jeffrey; T M Macdonald; M Rutter; S Freestone; J Brown; R R Samson; M R Lee
Journal:  Clin Sci (Lond)       Date:  1987-08       Impact factor: 6.124

4.  A microassay for active and total renin concentration in human plasma based on antibody trapping.

Authors:  J A Millar; B J Leckie; J J Morton; J Jordan; M Tree
Journal:  Clin Chim Acta       Date:  1980-02-14       Impact factor: 3.786

5.  Atrial natriuretic peptide in human essential hypertension.

Authors:  P K Zachariah; J C Burnett; S G Ritter; C G Strong
Journal:  Mayo Clin Proc       Date:  1987-09       Impact factor: 7.616

6.  Studies on the natriuretic effect of nifedipine in hypertensive patients: increase in levels of plasma atrial natriuretic factor without participation of the renal kallikrein-kinin system.

Authors:  A Rappelli; P Dessì-Fulgheri; P Madeddu; N Glorioso
Journal:  J Hypertens Suppl       Date:  1987-12

7.  Verapamil impairs secretion of stimulated atrial natriuretic factor in humans.

Authors:  M C Haufe; R Gerzer; J Weil; J E Ernst; K Theisen
Journal:  J Am Coll Cardiol       Date:  1988-06       Impact factor: 24.094

8.  Plasma and urine dopamine in man given sodium chloride in the diet.

Authors:  N S Oates; S G Ball; C M Perkins; M R Lee
Journal:  Clin Sci (Lond)       Date:  1979-03       Impact factor: 6.124

9.  The renal effects of atrial natriuretic peptide in man are not attenuated by (+)-sulpiride.

Authors:  S Freestone; T M MacDonald; R F Jeffrey; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

10.  Effects of calcium antagonists and nitroglycerin on atrial natriuretic peptide in normal subjects and patients with essential hypertension.

Authors:  T Iwasaki; A Niwa; T Shinoda; M Ishihara; T Aizawa; T Yamada
Journal:  Angiology       Date:  1989-01       Impact factor: 3.619

View more
  3 in total

Review 1.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 2.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

Review 3.  Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus.

Authors:  E Jungmann; K H Usadel
Journal:  Clin Investig       Date:  1992-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.